<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Cross-border spread of AMR |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</title>
  <meta name="description" content="<br />
97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</p>" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="Cross-border spread of AMR |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Cross-border spread of AMR |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
  
  
  

<meta name="author" content="Russell E. Lewis, Associate Professor, Infectious Diseases, University of Bologna" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="one-health-perspective-of-amr.html"/>
<link rel="next" href="summary.html"/>
<script src="assets/header-attrs-2.11/header-attrs.js"></script>
<script src="assets/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="assets/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="assets/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="assets/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Welcome</a></li>
<li class="chapter" data-level="" data-path="module-1-global-aspects-of-antimicrobial-resistance.html"><a href="module-1-global-aspects-of-antimicrobial-resistance.html"><i class="fa fa-check"></i>Module 1: Global Aspects of Antimicrobial Resistance</a>
<ul>
<li class="chapter" data-level="" data-path="a-brief-history-of-antimicrobial-resistance-amr.html"><a href="a-brief-history-of-antimicrobial-resistance-amr.html"><i class="fa fa-check"></i>A brief history of antimicrobial resistance (AMR)</a></li>
<li class="chapter" data-level="" data-path="global-response-to-antimicrobial-resistance.html"><a href="global-response-to-antimicrobial-resistance.html"><i class="fa fa-check"></i>Global response to antimicrobial resistance</a></li>
<li class="chapter" data-level="" data-path="what-are-the-drivers-of-antimicrobial-resistance.html"><a href="what-are-the-drivers-of-antimicrobial-resistance.html"><i class="fa fa-check"></i>What are the drivers of antimicrobial resistance?</a></li>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html"><i class="fa fa-check"></i>AMR in Low-Middle Income Countries (LMICs)</a>
<ul>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html#how-can-the-effectiveness-of-antimicrobials-be-preserved"><i class="fa fa-check"></i>How can the effectiveness of antimicrobials be preserved?</a></li>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html#case-study-a-successful-national-antibiotic-stewardship-program-in-a-lmic"><i class="fa fa-check"></i>Case study: A successful national antibiotic stewardship program in a LMIC</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="amr-situation-in-italy.html"><a href="amr-situation-in-italy.html"><i class="fa fa-check"></i>AMR situation in Italy</a></li>
<li class="chapter" data-level="" data-path="the-global-future-of-amr.html"><a href="the-global-future-of-amr.html"><i class="fa fa-check"></i>The global future of AMR</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html"><i class="fa fa-check"></i>One-Health Perspective of AMR</a>
<ul>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#antibiotic-use-in-animal-food-production"><i class="fa fa-check"></i>Antibiotic use in animal food production</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#the-impact-of-animal-antibiotic-use-on-human-amr"><i class="fa fa-check"></i>The impact of animal antibiotic use on human AMR</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#antimicrobial-resistance-in-animals-in-lmics"><i class="fa fa-check"></i>Antimicrobial resistance in animals in LMICs</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#environmental-concerns"><i class="fa fa-check"></i>Environmental concerns</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="cross-border-spread-of-amr.html"><a href="cross-border-spread-of-amr.html"><i class="fa fa-check"></i>Cross-border spread of AMR</a></li>
<li class="chapter" data-level="" data-path="summary.html"><a href="summary.html"><i class="fa fa-check"></i>Summary</a></li>
<li class="chapter" data-level="" data-path="lecture-slides.html"><a href="lecture-slides.html"><i class="fa fa-check"></i>Lecture Slides</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="module-2the-public-health-crisis-of-new-antibiotic-development.html"><a href="module-2the-public-health-crisis-of-new-antibiotic-development.html"><i class="fa fa-check"></i>Module 2:The Public Health Crisis of New Antibiotic Development</a>
<ul>
<li class="chapter" data-level="" data-path="background.html"><a href="background.html"><i class="fa fa-check"></i>Background</a></li>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html"><i class="fa fa-check"></i>Why has antibiotic discovery faltered in recent years?</a>
<ul>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#scientific-challenges"><i class="fa fa-check"></i>Scientific challenges</a></li>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#antibiotic-regulatory-hurdles"><i class="fa fa-check"></i>Antibiotic regulatory hurdles</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><i class="fa fa-check"></i>What are the current strategies to incentive antibiotic development?</a>
<ul>
<li class="chapter" data-level="" data-path="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html#antibiotic-supply-chain-problems"><i class="fa fa-check"></i>Antibiotic supply chain problems</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><i class="fa fa-check"></i>What can be done to ensure antibiotic access in LMICs?</a>
<ul>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-1-weak-drug-discovery-difficulties-in-market-entry-and-poor-stewardship-lead-to-irrational-selection-and-use-of-antibiotics"><i class="fa fa-check"></i>Barrier 1: Weak drug discovery, difficulties in market entry, and poor stewardship lead to irrational selection and use of antibiotics</a></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-2-antibiotics-are-not-affordable-for-many-in-lmics-and-government-funding-for-health-is-low"><i class="fa fa-check"></i>Barrier 2: Antibiotics are not affordable for many in LMICs and government funding for health is low</a></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-3-weak-health-systems-unreliable-supply-chains-and-poor-quality-control-fail-to-deliver-antibiotics-to-patients-in-need"><i class="fa fa-check"></i>Barrier 3: Weak health systems, unreliable supply chains and poor quality control fail to deliver antibiotics to patients in need</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="summary-1.html"><a href="summary-1.html"><i class="fa fa-check"></i>Summary</a></li>
<li class="chapter" data-level="" data-path="lecture-slides-1.html"><a href="lecture-slides-1.html"><i class="fa fa-check"></i>Lecture Slides</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="module-3-antibiotic-and-diagnostic-test-availability-affordibility.html"><a href="module-3-antibiotic-and-diagnostic-test-availability-affordibility.html"><i class="fa fa-check"></i>Module 3: Antibiotic and diagnostic test availability, affordibility</a>
<ul>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><i class="fa fa-check"></i>COVID-19 Vaccine Access in Low-Middle Income Countries (LMICs)</a>
<ul>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#covid-19-vaccines-global-access-covax-program"><i class="fa fa-check"></i>COVID-19 Vaccines Global Access (COVAX) Program</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#how-is-covax-working"><i class="fa fa-check"></i>How is COVAX working?</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#access-to-sars-cov-2-testing-in-lmics"><i class="fa fa-check"></i>Access to SARS-CoV-2 testing in LMICs</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#infection-control-in-lmics"><i class="fa fa-check"></i>Infection control in LMICs</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#intensive-care-units-icus-in-lmics"><i class="fa fa-check"></i>Intensive care units (ICUs) in LMICs</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="access-to-covid-19-tools-accelerator-act.html"><a href="access-to-covid-19-tools-accelerator-act.html"><i class="fa fa-check"></i>ACCESS TO COVID-19 Tools Accelerator (ACT)</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html"><i class="fa fa-check"></i>Medicines Patent Pool</a>
<ul>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#mpp-and-covid-19"><i class="fa fa-check"></i>MPP and COVID-19</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#mpp-and-hiv"><i class="fa fa-check"></i>MPP and HIV</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#mpp-and-hepatitis-c"><i class="fa fa-check"></i>MPP and Hepatitis C</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#tuberculosis"><i class="fa fa-check"></i>Tuberculosis</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#is-the-medicines-patient-pool-working"><i class="fa fa-check"></i>Is the Medicines Patient Pool Working?</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html"><i class="fa fa-check"></i>Counterfeit Medications</a>
<ul>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html#specific-problems-with-counterfeited-antibiotics"><i class="fa fa-check"></i>Specific problems with counterfeited antibiotics</a></li>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html#how-can-drug-counterfeiting-be-reduced"><i class="fa fa-check"></i>How can drug counterfeiting be reduced?</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="covid-19-and-lessons-for-the-amr-crises.html"><a href="covid-19-and-lessons-for-the-amr-crises.html"><i class="fa fa-check"></i>COVID-19 and lessons for the AMR crises</a></li>
<li class="chapter" data-level="" data-path="slides.html"><a href="slides.html"><i class="fa fa-check"></i>Slides</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
</ul></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./"><p><img src="images/logo.png" style="width:1in" /><br />
97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</p></a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="cross-border-spread-of-amr" class="section level2 unnumbered">
<h2>Cross-border spread of AMR</h2>
<figure>
<center>
<p><img src="images/worldairlineroute2014.png" width="800" /></p>
<figcaption>
<p><strong>Figure 16. World airline travel routes in 2014.</strong> Photo credit Jpatokal/Wikimedia (CC BY-SA 2.5)</p>
</figcaption>
</center>
</figure>
<p>The COVID-19 pandemic has exposed the limitations of global collaboration and response within existing global health frameworks, pointing to a clear need for more rules-based global governance to be able to effectively prevent, prepare and respond to health emergencies in a more just equitable way. However, valuable lessons from COVID-19 pandemic could enhance actions against AMR. (Table 1.2). Clearly, actions taken by one country have had substantial consequences for others. governments should significantly bolster global and national capacity to prevent and respond to global cross-border health threats more broadly.</p>
<figcaption>
<p>Table 1.2 Global successes and shortcomings in the multilateral response to the COVID-19 pandemic. Table is from Jit et al 2021.<span class="citation"><sup><a href="#ref-JitEtAl2021" role="doc-biblioref">25</a></sup></span></p>
</figcaption>
</center>
</figure>
<table>
<colgroup>
<col width="16%" />
<col width="45%" />
<col width="37%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Domain</th>
<th align="left">Successes</th>
<th align="left">Shortcomings</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left"><strong>Research collaboration and information sharing</strong></td>
<td align="left"><ul>
<li><p>Sharing of information by researchers</p></li>
<li><p>International research collaborations</p></li>
<li><p>Public data repositories</p></li>
</ul></td>
<td align="left"><ul>
<li><p>Many regions and countries slow to learn policy lessons from elsewhere</p></li>
<li><p>Lack of systemic global research governance</p></li>
<li><p>Duplication of research studies</p></li>
</ul></td>
</tr>
<tr class="even">
<td align="left"><strong>Vaccine discovery and development</strong></td>
<td align="left"><ul>
<li><p>Multinational initiatives to fund efforts such as the Coronavirus Global Response and the Coalition for Epidemic Preparedness Innovations</p></li>
<li><p>Approval of vaccines and adjuvants</p></li>
<li><p>Establishing the principle of equitable vaccine distribution through the COVAX Facility (despite failures in implementation)</p></li>
</ul></td>
<td align="left"><ul>
<li><p>Most funding from national efforts</p></li>
<li><p>Most vaccine doses secured by rich countries through bilateral deals</p></li>
<li><p>Trade barriers around vaccines and raw materials</p></li>
</ul></td>
</tr>
<tr class="odd">
<td align="left"><strong>Travel policies</strong></td>
<td align="left"><ul>
<li>Travel restrictions delayed spread from China in early 2020</li>
</ul></td>
<td align="left"><ul>
<li><p>Dissonant COVID-19 response policies between highly connected nations</p></li>
<li><p>Restrictions on travel to countries of high COVID-19 incidence contribute little to control in these countries</p></li>
</ul></td>
</tr>
</tbody>
</table>
<p><strong>The actions of the EU during the pandemic illustrate the tension between short-term nationalistic incentives and long-term imperatives for cooperation towards achieving global public goods such as reducing antimicrobial resistance.</strong> The EU has struggled to balance preferences of individual member-states (and those of their political leaderships), with the collective interests of all member-states. Such tensions are especially challenging when health care and health policy issues are involved, given how these have hitherto remained largely the responsibility of the member-states. In a pandemic, this can lead to inertia and political indecisiveness at the EU level, with member-states filling the gap with potentially contradictory or competing decisions.</p>
<p>Looking ahead, it is likely that there will be several changes to the global health architecture, possibly including a new pandemic treaty and additional international collaborative mechanisms to promote preparedness and coordinate responses. In the following sections, we explore what those developments might look like in three key areas.</p>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body">
<div id="ref-JitEtAl2021" class="csl-entry">
<div class="csl-left-margin">25 </div><div class="csl-right-inline">Jit M, Ananthakrishnan A, McKee M, Wouters OJ, Beutels P, Teerawattananon Y. Multi-country collaboration in responding to global infectious disease threats: Lessons for <span>Europe</span> from the <span>COVID-19</span> pandemic. <em>The Lancet Regional Health  Europe</em> 2021; <strong>9</strong>. DOI:<a href="https://doi.org/10.1016/j.lanepe.2021.100221">10.1016/j.lanepe.2021.100221</a>.</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="one-health-perspective-of-amr.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="summary.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="assets/gitbook-2.6.7/js/app.min.js"></script>
<script src="assets/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="assets/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection"
},
"toolbar": {
"position": "static"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
